Cytomedix has received FDA approval for its Angel concentrated platelet rich plasma system for processing a small sample of blood or a mixture of blood and bone marrow aspirate. The Angel PRP System is intended to be used in the clinic or intraoperatively at the point-of care for the safe and rapid preparation of platelet rich plasma from a small sample of whole blood or a small mixture of blood and bone marrow. The system is designed to produce consistently high platelet yields using a fully automated process and represents a significant engineering advance in autologous whole blood and bone marrow separation.
More Articles on PRP:
Dr. Mark Galland Releases Podcast on PRP
57 Sports Medicine Practices to Know
Dr. Stephen Weber Concludes Platelet-Rich Plasma Not Beneficial in Rotator Cuff Surgery